Last update :
31/03/2026
Various   Denosumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bomyntra France
Jubbonti France
Jubereq France
Obodence France
Osenvelt France
Osvyrti France
Prolia Argentina, Australia, Belgium, Brazil, Canada, Chile, Croatia, Finland, Germany, Great Britain, Hungary, Ireland, Italy, Luxembourg, Malaysia, Mexico, Norway, Peru, Spain, Sweden, Switzerland, Turkey
Stoboclo France
Wyost France
Xbryk France
Xgeva Argentina, Australia, Belgium, Brazil, Canada, Chile, Croatia, Finland, France, Germany, Great Britain, Hungary, Ireland, Italy, Luxembourg, Malaysia, Mexico, Norway, Romania, Spain, Sweden, Switzerland, Turkey
References   injection   References : Denosumab  
Type Publication
5187 Manufacturer Xbryk 120 mg solution injectable - Résumé des caractéristiques du produit.
Samsung Bioepis NL B.V. 2025

  Mentions Légales